NCT07106684: ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Primary Plasma Cell Leukemia
- State
- Under way
- Phase
- Phase 2
- People
- 20 planned
- Started
- 9 Aug 2025
- Primary completion
- 1 Aug 2027
- Arms
- ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance
- Results
- None posted
- 6 Aug 2025: Trial registered
- 9 Aug 2025: Trial started